Ferroptosis rewired: ncRNA gatekeepers as pharmacological targets in hepatocellular carcinoma
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-12 · 398 (12) · 16577-16597
DOI: 10.1007/s00210-025-04404-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 07.07.2025. Verfasst von Abdulrahman T Ahmed und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Nursing, University of Al Maarif, Ramadi, Al Anbar, 31001, Iraq. Abdulrahman.dheyab@uoa.edu.iq. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Untranslated. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 146 Literaturangaben.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) can alter cellular programs, such as iron homeostasis and antioxidant defenses, creating a pathway to ferroptosis, an iron-dependent mechanism of cellular death, as a viable therapeutic approach. Non-coding RNAs (ncRNAs), including both microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), have recently been shown to be potent regulatory molecules involved in gene expression and cell fates, including apoptosis and inflammation. This review summarizes the current literature regarding ncRNAs' multiple and complex roles in mediating HCC ferroptosis. We focus on mechanistic insights into how ncRNAs regulate some major ferroptosis regulators (e.g., SLC7A11/GPX4 axis, iron metabolism, and lipid peroxidation). We also highlight recent research evidence of the interconnection between ncRNA-modulated regulation of ferroptosis and inflammation in HCC development. This review thoughtfully evaluates studies that have identified ncRNAs functioning as either promoters or suppressors of ferroptosis and their impacts on the inflammatory response within the tumor microenvironment. Finally, we discuss the prognostic roles of these ncRNAs and the potential for ncRNAs to be used as diagnostic and therapeutic biomarkers in HCC. Finally, through an accumulated body of literature, we try to create a cohesive understanding of ncRNAs' role in ferroptosis and inflammation in HCC, pointing to promising avenues for future research and clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Nursing, University of Al Maarif, Ramadi, Al Anbar, 31001, Iraq. Abdulrahman.dheyab@uoa.edu.iq.
- Medical Laboratory Techniques Department, College of Health and Medical Technology, University of Al-Maarif, Ramadi, Anbar, Iraq. Abdulrahman.dheyab@uoa.edu.iq.
- Department of Pharmacy, Al-Zahrawi University College, Karbala, Iraq.
- Marwadi University Research Center, Department of Microbiology, Faculty of Science, Marwadi University, Rajkot, Gujarat, 360003, India.
- Department of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to Be University), Bangalore, Karnataka, India.
- Centre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab, 140401, India.
Zitieren
APA
Ahmed, A. T., Jawad, M., Sanghvi, G., R, R., Kashyap, A., Al-Hetty, H. R. A. K., Gayathri, S., Panigrahi, R., Mustafa, Y. F., & Kadhim, W. D. (2025). Ferroptosis rewired: ncRNA gatekeepers as pharmacological targets in hepatocellular carcinoma. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(12), 16577-16597. https://doi.org/10.1007/s00210-025-04404-4
Vancouver
Ahmed AT, Jawad M, Sanghvi G, R R, Kashyap A, Al-Hetty HRAK, et al. Ferroptosis rewired: ncRNA gatekeepers as pharmacological targets in hepatocellular carcinoma. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(12):16577-16597. doi:10.1007/s00210-025-04404-4
BibTeX
@article{Ahmed2025,
author = {Ahmed, Abdulrahman T and Jawad, Mahmood and Sanghvi, Gaurav and R, Roopashree and Kashyap, Aditya and Al-Hetty, Hussein Riyadh Abdul Kareem and Gayathri, S and Panigrahi, Rajashree and Mustafa, Yasser Fakri and Kadhim, Wael Dheaa},
title = {Ferroptosis rewired: ncRNA gatekeepers as pharmacological targets in hepatocellular carcinoma},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
volume = {398},
number = {12},
pages = {16577--16597},
doi = {10.1007/s00210-025-04404-4}
}
EUVIMED